Clinical Trial Update: Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating durvalumab in combination with radiation therapy for early-stage non-small cell lung cancer. The study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: NSCLC, Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING